| -LD patients1
| +LD patients1
|
---|
ALT/AST DAIDS >22
| Hepatic SAE | Hepatic SAE |
---|
| Yes | No | Yes | No |
---|
Yes | 3 | 107 | 1 | 29 |
No | 6 | 970 | 4 | 141 |
-
1Thirty-two patients had missing information and were unable to be classified into one of the two risk groups; none of these patients experienced a hepatic SAE.
- +LD = patients with underlying liver disease (baseline evidence of active HBV/HCV infection or ALT/AST Grade >1); -LD = patients with no apparent liver disease (absence of active HBV/HCV infection and ALT/AST Grade ≤ 1); ALT = alanine aminotransferase; AST = aspartate aminotransferase; DAIDS = Division of AIDS; HBV = hepatitis B virus; HCV = hepatitis C virus; TPV/r = ritonavir-boosted tipranavir
-
2ALT/AST on treatment DAIDS Grade 3/4